Press release Published: 01-12-18 15:20:00

Oncology Venture: Publication of supplement to prospectus

Oncology Venture Sweden AB ("Oncology Venture") hereby publish a supplement to the prospectus due to the press release the company published on January 8th, 2018, which was published after the approval of the company's prospectus by the Swedish Financial Supervisory Authority prior to Oncology Venture's rights issue with subscription period on January 11th - January 25th, 2018. The supplement to the prospectus is available on the company's (, Sedermera Fondkommission's ( and AktieTorget's ( respective websites.